Akanda CORP F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
Akanda Corp. files an amended F-1 registration statement, outlining a strategic pivot from cannabis to telecommunications infrastructure in Mexico through its First Towers acquisition, alongside recent financing and ongoing operational challenges.
NASDAQ
Akanda Corp. filed an amended F-1 registration statement, outlining past unregistered securities sales, director indemnification, and a new $2.3 million marketing agreement with IR Agency LLC.
NASDAQ
Akanda Corp. is registering 30.3 million common shares for resale by selling stockholders, following its strategic acquisition of Mexican telecom infrastructure company First Towers and a pivot away from its European cannabis operations.
NASDAQ
Akanda Corp. filed an amendment to its F-1 registration statement to register 18,761,062 common shares for resale by selling stockholders, stemming from the conversion of $12 million in promissory notes.
NASDAQ
Akanda Corp. files an F-1 registration statement for the resale of up to 18.76 million common shares, following its acquisition of First Towers & Fiber Corp. and a $12 million convertible note offering, while discontinuing its UK cannabis operations.
NASDAQ
Akanda Corp. plans to offer 1,271,186 common shares and pre-funded warrants to generate gross proceeds of $1.5 million for general corporate purposes.
NASDAQ
Akanda Corp. announces a proposed public offering of common shares and pre-funded warrants to raise $1.5 million for capital expenditures, working capital, and potential acquisitions.
NASDAQ
Akanda Corp plans to offer up to 85,365,854 common shares and pre-funded warrants to raise capital for various corporate purposes.
NASDAQ
Akanda Corp. plans to offer common shares and pre-funded warrants to purchase common shares, aiming to raise capital for various corporate purposes.
NASDAQ
Akanda Corp. files for a public offering of common shares and warrants to fund capital expenditures, operations, and potential acquisitions in the burgeoning medical cannabis sector.